Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
A Multi-Center Study To Examine The Clinical Effects Of Cross Titration Of Antipsychotics With Ziprasidone In Subjects With Schizophrenia Or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ChanghuaZiprasidone Intramuscular/Oral In The Treatment Of Acute Exacerbation Of Schizophrenia Or Schizoaffective Disorder: A Six-Week Open Administration Study
This study has finished and is no longer accepting participants.
Multiple locations, including MonterreyThis study evaluates the safety and effectiveness of Ziprasidone for people with schizophrenia.
This study ended early.
In Lisbon
Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment
This study has finished and is no longer accepting participants.
In PittsburghA Randomized, Open-Label Pharmacokinetic Study of LY03004 Compared to Risperdal® Consta® Following a Single Intramuscular Injection at 25 mg or 50 mg in Stable Patients With Schizophrenia and/or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Orange CountyThis study ended early.
In Los AngelesA Multicenter, Randomized, Double-blind, Placebo-controlled, 16 Week Study of Aripiprazole Used as Dual Therapy in the Treatment of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder Demonstrating an Inadequate Response to Quetiapine or Risperidone Monotherapy.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockComparison of Steady-state Pharmacokinetics of Paliperidone After Extended-release OROS� Paliperidone 15 mg and Immediate-release Oral Risperidone 8 mg b.i.d. in Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedA Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSafety and Efficacy of BXCL501, a Sublingual Film Delivery of Dexmedetomidine for the Treatment of Acute Agitation in Schizophrenia
This study has finished and is no longer accepting participants.
In New HavenCombined Treatment of Cardiovascular Risk Factors In Newly Admitted Patients With Schizophrenia or Schizoaffective Disorder Who Are Receiving Olanzapine And Matched Controls
This study was withdrawn before enrollment.
Multiple locations, including ButnerCognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study
This study has finished and is no longer accepting participants.
In Torre del GrecoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.